OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Concomitant pathologies among a spectrum of parkinsonian disorders
Brittany N. Dugger, Charles H. Adler, Holly A. Shill, et al.
Parkinsonism & Related Disorders (2014) Vol. 20, Iss. 5, pp. 525-529
Open Access | Times Cited: 138
Brittany N. Dugger, Charles H. Adler, Holly A. Shill, et al.
Parkinsonism & Related Disorders (2014) Vol. 20, Iss. 5, pp. 525-529
Open Access | Times Cited: 138
Showing 1-25 of 138 citing articles:
Pathology of Neurodegenerative Diseases
Brittany N. Dugger, Dennis W. Dickson
Cold Spring Harbor Perspectives in Biology (2017) Vol. 9, Iss. 7, pp. a028035-a028035
Open Access | Times Cited: 1284
Brittany N. Dugger, Dennis W. Dickson
Cold Spring Harbor Perspectives in Biology (2017) Vol. 9, Iss. 7, pp. a028035-a028035
Open Access | Times Cited: 1284
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
John Robinson, Edward B. Lee, Sharon X. Xie, et al.
Brain (2018) Vol. 141, Iss. 7, pp. 2181-2193
Open Access | Times Cited: 566
John Robinson, Edward B. Lee, Sharon X. Xie, et al.
Brain (2018) Vol. 141, Iss. 7, pp. 2181-2193
Open Access | Times Cited: 566
Thomas G. Beach, Charles H. Adler, Lucia I. Sue, et al.
Neuropathology (2015) Vol. 35, Iss. 4, pp. 354-389
Open Access | Times Cited: 409
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
Adam L. Boxer, Jin‐Tai Yu, Lawrence I. Golbe, et al.
The Lancet Neurology (2017) Vol. 16, Iss. 7, pp. 552-563
Open Access | Times Cited: 401
Adam L. Boxer, Jin‐Tai Yu, Lawrence I. Golbe, et al.
The Lancet Neurology (2017) Vol. 16, Iss. 7, pp. 552-563
Open Access | Times Cited: 401
Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
Anthony E. Lang, Alberto J. Espay
Movement Disorders (2018) Vol. 33, Iss. 5, pp. 660-677
Open Access | Times Cited: 319
Anthony E. Lang, Alberto J. Espay
Movement Disorders (2018) Vol. 33, Iss. 5, pp. 660-677
Open Access | Times Cited: 319
Dementia with Lewy bodies: an update and outlook
Tiago F. Outeiro, David J. Koss, Daniel Erskine, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 298
Tiago F. Outeiro, David J. Koss, Daniel Erskine, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 298
Prodromal Parkinson disease subtypes — key to understanding heterogeneity
Daniela Berg, Per Borghammer, Seyed‐Mohammad Fereshtehnejad, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 6, pp. 349-361
Closed Access | Times Cited: 272
Daniela Berg, Per Borghammer, Seyed‐Mohammad Fereshtehnejad, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 6, pp. 349-361
Closed Access | Times Cited: 272
Genetics and Pathogenesis of Parkinson's Syndrome
Hui Ye, Laurie Robak, Meigen Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 95-121
Open Access | Times Cited: 213
Hui Ye, Laurie Robak, Meigen Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 95-121
Open Access | Times Cited: 213
Neuropathology and molecular diagnosis of Synucleinopathies
Shunsuke Koga, Hiroaki Sekiya, Naveen Kondru, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 201
Shunsuke Koga, Hiroaki Sekiya, Naveen Kondru, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 201
Altered Proteins in the Aging Brain
Adila El‐Obeid, Sylwia Libard, Marina Leino, et al.
Journal of Neuropathology & Experimental Neurology (2016) Vol. 75, Iss. 4, pp. 316-325
Open Access | Times Cited: 176
Adila El‐Obeid, Sylwia Libard, Marina Leino, et al.
Journal of Neuropathology & Experimental Neurology (2016) Vol. 75, Iss. 4, pp. 316-325
Open Access | Times Cited: 176
Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons
Alifiya Kapasi, Julie A. Schneider
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2016) Vol. 1862, Iss. 5, pp. 878-886
Open Access | Times Cited: 172
Alifiya Kapasi, Julie A. Schneider
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2016) Vol. 1862, Iss. 5, pp. 878-886
Open Access | Times Cited: 172
Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults
Shama Karanth, Peter T. Nelson, Yuriko Katsumata, et al.
JAMA Neurology (2020) Vol. 77, Iss. 10, pp. 1299-1299
Open Access | Times Cited: 163
Shama Karanth, Peter T. Nelson, Yuriko Katsumata, et al.
JAMA Neurology (2020) Vol. 77, Iss. 10, pp. 1299-1299
Open Access | Times Cited: 163
Parkinson’s Disease
Caroline M. Tanner, Jill L. Ostrem
New England Journal of Medicine (2024) Vol. 391, Iss. 5, pp. 442-452
Closed Access | Times Cited: 31
Caroline M. Tanner, Jill L. Ostrem
New England Journal of Medicine (2024) Vol. 391, Iss. 5, pp. 442-452
Closed Access | Times Cited: 31
Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder
Aline Delva, Amélie Pelletier, Emma N. Somerville, et al.
Brain (2025)
Closed Access | Times Cited: 2
Aline Delva, Amélie Pelletier, Emma N. Somerville, et al.
Brain (2025)
Closed Access | Times Cited: 2
Precision medicine for disease modification in Parkinson disease
Alberto J. Espay, Patrik Brundin, Anthony E. Lang
Nature Reviews Neurology (2017) Vol. 13, Iss. 2, pp. 119-126
Closed Access | Times Cited: 161
Alberto J. Espay, Patrik Brundin, Anthony E. Lang
Nature Reviews Neurology (2017) Vol. 13, Iss. 2, pp. 119-126
Closed Access | Times Cited: 161
Alzheimer's disease and other neurodegenerative dementias in comorbidity: A clinical and neuropathological overview
Radoslav Matěj, Adam Tesař, Robert Rusina
Clinical Biochemistry (2019) Vol. 73, pp. 26-31
Closed Access | Times Cited: 119
Radoslav Matěj, Adam Tesař, Robert Rusina
Clinical Biochemistry (2019) Vol. 73, pp. 26-31
Closed Access | Times Cited: 119
Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy
Farwa Ali, Peter R. Martin, Hugo Botha, et al.
Movement Disorders (2019) Vol. 34, Iss. 8, pp. 1144-1153
Open Access | Times Cited: 118
Farwa Ali, Peter R. Martin, Hugo Botha, et al.
Movement Disorders (2019) Vol. 34, Iss. 8, pp. 1144-1153
Open Access | Times Cited: 118
Diagnostic impact of [18F]flutemetamol PET in early-onset dementia
Marissa D. Zwan, Femke H. Bouwman, Elles Konijnenberg, et al.
Alzheimer s Research & Therapy (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 111
Marissa D. Zwan, Femke H. Bouwman, Elles Konijnenberg, et al.
Alzheimer s Research & Therapy (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 111
Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases
Gábor G. Kovács, John Robinson, Sharon X. Xie, et al.
Journal of Neuropathology & Experimental Neurology (2017) Vol. 76, Iss. 4, pp. 270-288
Open Access | Times Cited: 109
Gábor G. Kovács, John Robinson, Sharon X. Xie, et al.
Journal of Neuropathology & Experimental Neurology (2017) Vol. 76, Iss. 4, pp. 270-288
Open Access | Times Cited: 109
Cerebrospinal Fluid Alzheimer’s Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort
Inger van Steenoven, Dag Aarsland, Daniel Weintraub, et al.
Journal of Alzheimer s Disease (2016) Vol. 54, Iss. 1, pp. 287-295
Open Access | Times Cited: 100
Inger van Steenoven, Dag Aarsland, Daniel Weintraub, et al.
Journal of Alzheimer s Disease (2016) Vol. 54, Iss. 1, pp. 287-295
Open Access | Times Cited: 100
Clinical Approach to Progressive Supranuclear Palsy
Helen Ling
Journal of Movement Disorders (2016) Vol. 9, Iss. 1, pp. 3-13
Open Access | Times Cited: 86
Helen Ling
Journal of Movement Disorders (2016) Vol. 9, Iss. 1, pp. 3-13
Open Access | Times Cited: 86
Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
Naomi P. Visanji, Anthony E. Lang, Gábor G. Kovács
Translational Neurodegeneration (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 84
Naomi P. Visanji, Anthony E. Lang, Gábor G. Kovács
Translational Neurodegeneration (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 84
What causes neurodegenerative disease?
Richard A. Armstrong
Folia Neuropathologica (2020) Vol. 58, Iss. 2, pp. 93-112
Open Access | Times Cited: 84
Richard A. Armstrong
Folia Neuropathologica (2020) Vol. 58, Iss. 2, pp. 93-112
Open Access | Times Cited: 84
Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease
Ricardo Apátiga-Pérez, Luis O. Soto-Rojas, B. Berenice Campa-Córdoba, et al.
Metabolic Brain Disease (2021) Vol. 37, Iss. 1, pp. 39-50
Closed Access | Times Cited: 69
Ricardo Apátiga-Pérez, Luis O. Soto-Rojas, B. Berenice Campa-Córdoba, et al.
Metabolic Brain Disease (2021) Vol. 37, Iss. 1, pp. 39-50
Closed Access | Times Cited: 69
Advances in Deep Neuropathological Phenotyping of Alzheimer Disease: Past, Present, and Future
Mustafa N Shakir, Brittany N. Dugger
Journal of Neuropathology & Experimental Neurology (2022) Vol. 81, Iss. 1, pp. 2-15
Open Access | Times Cited: 38
Mustafa N Shakir, Brittany N. Dugger
Journal of Neuropathology & Experimental Neurology (2022) Vol. 81, Iss. 1, pp. 2-15
Open Access | Times Cited: 38
